戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 bo, 170 [91%] on memantine, and 168 [90%] on trazodone).
2 euptake inhibitors, and 1.2 (1.0 to 1.4) for trazodone.
3 ribing included sertraline, mirtazapine, and trazodone.
4 ) did not differ significantly from that for trazodone.
5 ospital and 36 (15.3/1,000) total deaths for trazodone.
6 spital and 256 (15.8/1,000) total deaths for trazodone.
7  dementia might be preferentially prescribed trazodone.
8 stage two interim analysis for memantine and trazodone.
9 er month, -0.71; 95% CI, -1.19 to -0.24) and trazodone (-0.60; 95% CI, -1.09 to -0.11).
10 randomly allocated to memantine (183 [33%]), trazodone (185 [33%]), or placebo (186 [34%]).
11 ants were randomised (1:1:1) to receive oral trazodone 200 mg once a day, oral memantine 20 mg once a
12 tonin-reuptake inhibitors (612 subjects), or trazodone (304 subjects) or nonusers of antidepressants
13                      We investigated whether trazodone, a licensed antidepressant with hypnotic effic
14 vitro and animal studies have suggested that trazodone, a licensed antidepressant, may protect agains
15 or donepezil, sertraline, norsertraline, and trazodone across each of these early life stages of brow
16                                              Trazodone also improved rapid eye movement (REM) sleep,
17   Here we show that a chronic treatment with trazodone, an antidepressant with positive effects on sl
18 idol, aripiprazole, cariprazine, fluoxetine, trazodone and amiodarone.
19                                        Thus, trazodone and compounds with REM sleep-promoting propert
20           Thus, in prion-diseased mice, both trazodone and dibenzoylmethane treatment restored memory
21 rugs that increase 7-DHC levels such as ARI, trazodone and haloperidol.
22 luoxetine, its metabolite norfluoxetine, and trazodone and its active metabolite m-chlorophenylpipera
23 acting on serotonin signalling pathways e.g. trazodone and lorcaserin.
24 r to the chemically related drug vilazodone, trazodone and nefazodone are allosteric ligands: trazodo
25                                              Trazodone and nefazodone have long been used as antidepr
26 odone and nefazodone are allosteric ligands: trazodone and nefazodone inhibit uptake by and transport
27                                              Trazodone and nefazodone rescued a folding-deficient var
28                          The antidepressants trazodone and nefazodone were approved some 4 and 3 deca
29 LSFRS-R was -0.650 for memantine, -0.625 for trazodone, and -0.655 for placebo (memantine versus plac
30 ated memantine, 175 (33%) had been allocated trazodone, and 180 (34%) had been allocated placebo.
31 se event (37 [20%] on memantine, 27 [14%] on trazodone, and 24 [13%] on placebo).
32 iveness of a combination of serotoninergics, trazodone, and L-tryptophan, in our animal model of OSAH
33 nzodiazepines, daridorexant, suvorexant, and trazodone) can be effective in the acute treatment of in
34                  In a 9 week dosing regimen, trazodone decreased microglial NLRP3 inflammasome expres
35  to describe trends in zolpidem and low-dose trazodone dispensing among adults with employer-sponsore
36 18) were significantly increased relative to trazodone; findings were similar with exclusion of overd
37 lopram, citalopram, mirtazapine, duloxetine, trazodone, fluoxetine, bupropion, paroxetine, and venlaf
38                                              Trazodone, frequently prescribed in low doses for insomn
39 ths in the memantine group, 52 deaths in the trazodone group, and 48 deaths in the placebo group.
40 f 10%, indicating that neither memantine nor trazodone groups met the criteria for continuation.
41                               Topiramate and trazodone have limited evidence supporting efficacy for
42 pressants (B = 0.046; SE = 0.013; P < .001), trazodone hydrochloride (B = 0.033; SE = 0.010; P < .001
43                 We identified two compounds, trazodone hydrochloride and dibenzoylmethane, which reve
44 rperazine (HR, 0.47; 95% CI, 0.33-0.68), and trazodone hydrochloride vs. paroxetine (HR, 0.49; 95% CI
45                        Neither memantine nor trazodone improved efficacy outcomes compared with place
46 , to those for comparable patients receiving trazodone in doses up to 100 mg.
47                                              Trazodone in particular, a licensed drug, should now be
48 ese results suggest that the clinical use of trazodone is not associated with a reduced risk of demen
49                                              Trazodone/ L-tryptophan dose-dependently reduced sleep f
50                                              Trazodone/L-tryptophan caused dose-dependent reductions
51 y blocking this pathway with either ISRIB or trazodone limited cell migration.
52  have been conducted to assess the effect of trazodone on dementia in humans.
53             These findings on the effects of trazodone on the NLRP3 inflammasome, the unfolded protei
54 tly powered to warrant no further testing of trazodone or memantine in motor neuron disease at the do
55 ssociation with receiving a prescription for trazodone (OR = 1.38, p = 0.04).
56                                     Further, trazodone reduced p-tau burden.
57                                              Trazodone reduced theta oscillations during rapid eye mo
58  the pathway-including by the licensed drug, trazodone-restores global protein synthesis rates with p
59 tamol and triflusal, but not dimethadione or trazodone, significantly elevated FGF20 levels in the ni
60 nzodiazepine hypnotics, z-drugs, or low-dose trazodone, study hypnotics were not associated with mort
61 ezil, sertraline, norsertraline, citalopram, trazodone, telmisartan, and mirtazapine in eggs and yolk
62 ights into the neuroprotective mechanisms of trazodone through reversal of this toxicity, relevant fo
63 amine, amitriptyline, duloxetine, bupropion, trazodone, tianeptine, and agomelatine.
64  dementia among patients who were prescribed trazodone to that of patients with similar baseline char
65                                  Remarkably, trazodone treatment for just 2 weeks largely restored th
66                                 In parallel, trazodone treatment restored the disease-associated decl
67 ains of prion-diseased mice with and without trazodone treatment, in both whole hippocampus and cell-
68 lth records, we found no association between trazodone use and a reduced risk of dementia compared wi
69 cords study assessed the association between trazodone use and the risk of developing dementia in cli
70 2017 clinical practice guideline discouraged trazodone use for insomnia.
71 90% CI lower level -0.085; one-sided p=0.36; trazodone vs placebo: 0.065, -0.051; one-sided p=0.24).
72  to dementia diagnosis for people prescribed trazodone was 1.8 years (interquartile range [IQR] = 0.5
73  Incidence of dementia among patients taking trazodone was higher than in matched users of other anti
74                                 Zolpidem and trazodone were the most widely prescribed initial sleep
75                          Patients prescribed trazodone who met the inclusion criteria (n = 4,716; 59.
76                                              Trazodone with L-tryptophan can treat sleep-disordered b